Sphera Funds Management Ltd.
About Sphera Funds Management Ltd.’s 13F portfolio
Sphera Funds Management Ltd. is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Sphera Funds Management Ltd. reported $698.8M across 97 US-listed positions (). Its largest position is TEVA PHARMACEUTICAL INDS LTD (TEVA) at 7.3% of the reported book, and its ten biggest holdings make up 36% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NYSE: TEVA TEVA PHARMACEUTICAL INDS LTD | — — | 7.3% | 1.5M | $50.8M |
| 2 | NASDAQ: MLYS MINERALYS THERAPEUTICS INC | — — | 5.7% | 1.5M | $39.7M |
| 3 | NASDAQ: TSEM TOWER SEMICONDUCTOR LTD | — — | 4.0% | 108K | $28.2M |
| 4 | NASDAQ: SNDX SYNDAX PHARMACEUTICALS INC | — — | 3.2% | 1.0M | $22.2M |
| 5 | NASDAQ: BIIB BIOGEN INC | — — | 3.0% | 97K | $20.9M |
| 6 | NASDAQ: RARE ULTRAGENYX PHARMACEUTICAL IN | — — | 2.8% | 588K | $19.6M |
| 7 | NASDAQ: BMRN BIOMARIN PHARMACEUTICAL INC | — — | 2.7% | 329K | $18.8M |
| 8 | NASDAQ: CYTK CYTOKINETICS INC | — — | 2.7% | 220K | $18.7M |
| 9 | NASDAQ: BBIO BRIDGEBIO PHARMA INC | — — | 2.6% | 245K | $18.3M |
| 10 | NASDAQ: COGT COGENT BIOSCIENCES INC | — — | 2.5% | 459K | $17.8M |
| 11 | NASDAQ: NVMI NOVA LTD | — — | 2.0% | 25K | $13.7M |
| 12 | NASDAQ: INSM INSMED INC | — — | 1.8% | 119K | $12.7M |
| 13 | NASDAQ: MAZE MAZE THERAPEUTICS INC | — — | 1.8% | 418K | $12.5M |
| 14 | NASDAQ: AZN ASTRAZENECA PLC | — — | 1.7% | 63K | $11.9M |
| 15 | NASDAQ: SNY SANOFI SA | — — | 1.6% | 270K | $11.5M |
| 16 | NASDAQ: HELP CYBIN INC | — — | 1.5% | 1.6M | $10.7M |
| 17 | NYSE: LLY ELI LILLY & CO | — — | 1.4% | 8K | $9.6M |
| 18 | NASDAQ: MDGL MADRIGAL PHARMACEUTICALS INC | — — | 1.3% | 17K | $9.4M |
| 19 | NASDAQ: TRVI TREVI THERAPEUTICS INC | — — | 1.3% | 499K | $9.3M |
| 20 | NASDAQ: ACAD ACADIA PHARMACEUTICALS INC | — — | 1.3% | 357K | $9.0M |
| 21 | NASDAQ: CLDX CELLDEX THERAPEUTICS INC NEW | — — | 1.3% | 241K | $9.0M |
| 22 | NASDAQ: RYTM RHYTHM PHARMACEUTICALS INC | — — | 1.3% | 80K | $8.9M |
| 23 | NASDAQ: ORIC ORIC PHARMACEUTICALS INC | — — | 1.2% | 753K | $8.2M |
| 24 | NASDAQ: LRCX LAM RESEARCH CORP | — — | 1.1% | 18K | $8.0M |
| 25 | NASDAQ: AMAT APPLIED MATLS INC | — — | 1.1% | 11K | $8.0M |
Showing 1–25 of 97 positions on this page reported in this 13F.
- Healthcare84%
- Technology9.4%
- Utilities1.5%
- AddedTEVATEVA PHARMACEUTICAL INDS LTD+31.9%$50.8M
- AddedMLYSMINERALYS THERAPEUTICS INC+9.7%$39.7M
- AddedSNDXSYNDAX PHARMACEUTICALS INC+40.0%$22.2M
- AddedBIIBBIOGEN INC+4.4%$20.9M
- AddedBMRNBIOMARIN PHARMACEUTICAL INC+135%$18.8M
- AddedCYTKCYTOKINETICS INC+452%$18.7M
- AddedBBIOBRIDGEBIO PHARMA INC+0.0%$18.3M
- AddedCOGTCOGENT BIOSCIENCES INC+10.3%$17.8M
- NewINSMINSMED INC—$12.7M
- AddedMAZEMAZE THERAPEUTICS INC+83.7%$12.5M
- ReducedTSEMTOWER SEMICONDUCTOR LTD−25.7%$28.2M
- ReducedRAREULTRAGENYX PHARMACEUTICAL IN−27.3%$19.6M
- ReducedNVMINOVA LTD−52.8%$13.7M
- ReducedLLYELI LILLY & CO−11.1%$9.6M
- ReducedTRVITREVI THERAPEUTICS INC−13.1%$9.3M
- ReducedCLDXCELLDEX THERAPEUTICS INC NEW−1.1%$9.0M
- ReducedTNGXTANGO THERAPEUTICS INC−26.0%$7.9M
- ReducedXENEXENON PHARMACEUTICALS INC−17.3%$6.3M
- ReducedELVNENLIVEN THERAPEUTICS INC−26.4%$5.7M
- ReducedGSKGSK PLC−16.4%$5.3M
Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.
| # | Stock | Type | % of class | Shares | Filed |
|---|---|---|---|---|---|
| 1 | TENX Tenax Therapeutics, Inc. | 13G | 7.1% | 2.7M | Filed 13 OCT 2026 |
Showing all 1 disclosed stakes.
Reading Sphera Funds Management Ltd.’s 13F portfolio
Sphera Funds Management Ltd.’s $698.8M 13F book is spread across 97 reported positions and is moderately diversified, the ten largest names accounting for 36%. There are meaningful positions at the top alongside a long tail of smaller holdings. Its five largest positions are TEVA, MLYS, TSEM, SNDX and BIIB, led by TEVA PHARMACEUTICAL INDS LTD (TEVA) at 7.3% of the portfolio. The heaviest sector exposure is Healthcare (84%), then Technology (9%).
What Sphera Funds Management Ltd. changed last quarter
Between 2026-03-31 and Q2 2026, Sphera Funds Management Ltd. was a net buyer: it opened 22 new positions and added to 33 more, while trimming 28 and closing 17 outright. Against a 97-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was TEVA PHARMACEUTICAL INDS LTD (TEVA), and its biggest reduction was TOWER SEMICONDUCTOR LTD (TSEM).
What a 13F does and doesn’t reveal
A 13F captures only Sphera Funds Management Ltd.’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Sphera Funds Management Ltd. is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Sphera Funds Management Ltd.'s profile on this page is built directly from those filings.
How current is the 13F data on Sphera Funds Management Ltd.'s page?
It reflects Sphera Funds Management Ltd.'s most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Sphera Funds Management Ltd. files its next quarterly report, this page refreshes automatically.
Can I see Sphera Funds Management Ltd.'s complete list of holdings?
This page highlights Sphera Funds Management Ltd.'s largest positions rather than all 97 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Sphera Funds Management Ltd.'s filings.
Does a 13F show everything Sphera Funds Management Ltd. owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Sphera Funds Management Ltd.'s book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Sphera Funds Management Ltd. made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

